If you liked this article you might like

5 Earnings Short-Squeeze Plays: Twitter, Sarepta Therapeutics Included
Sarepta Pops on Bullish Sentiment Around Duchenne Therapy, PDL Up on Merck Deal: Biotech Movers
It's Tough to Figure Out Where to Jump In
My Game Plan Is to Not Trust That Upside